Pre-Market Updates, Upgrades, Downgrades and More News | $BABA, $BKS, $YRD, $CS, $AMZN, $AAPL, $WFC, $TSLA, $DG, $ALXN, $CTRP

PRE-MARKET MOVERS

1. CWAY, HONE:  $CWAY HarborOne Bank $HONE to Acquire Coastway Bancorp – SI

2. CVTI:  $CVTI Chattanooga-based Covenant Transport raises profit outlook – GN

3. BKS:  $BKS Barnes & Noble shoots higher after guidance update – SA

4. ALXN:  $ALXN Alexion’s rare blood disorder drug succeeds in late-stage study – Reuters

5. DG:  $DG Dollar General shares jump after same-store sales beat, upbeat outlook – MW

6. LITB:  $LITB LightInTheBox Establishes Experimental Cryptocurrency Mining Operation in North America – SI

7. LJPC:  $LJPC La Jolla Pharmaceutical Prices 3.4M Shares Common Offering $29.50/Sh – SI

8. YRD:  $YRD Yirendai Reports Fourth Quarter and Full Year 2017 Financial Results – PRN

9. WSM:  $WSM Williams-Sonoma shares rally on earnings, outlook beat – MW

10. BABA:  $BABA China Tech Titan Alibaba Plans Stock-Market Homecoming – WSJ

11. CS, XIV:  $CS Credit Suisse is being sued for losses over a controversial financial product $XIV – CNBC

12. AMZN:  $AMZN Exclusive: Amazon’s internal numbers on Prime Video, revealed – Reuters

13. WFC:  $WFC Wells Fargo faces sanctions for auto insurance payouts – sources – Reuters

14. AKCA, IONS:  $IONS Ionis Sends Nerve Drug to Spinout Akcea as Battle w Alnylam Looms – Xconomy $AKCA

15. CTRP:  $CTRP China’s Ctrip Blames Scandal, Business Curbs for Sales Shortfall – BBG

16. BNFT:  $BNFT Benefitfocus Announces Fourth Quarter and Full Year 2017 Financial Results – GN

17. IVTY:  $IVTY Invuity Announces Proposed Public Offering of Common Stock – SI

UPGRADES

DOWNGRADES

EARNINGS

Trending Social Alerts

Educational Tip of the Day (SOURCE: NASDAQ.com):

Junk bond: A bond with a speculative credit rating of BB (S&P) or Ba (Moody’s) or lower. Junk or high-yield bonds offer investors higher yields than bonds of financially sound companies. Two agencies, Standard & Poors and Moody’s Investor Services, provide the rating systems forcompanies’ credit.

 

Strike price: The stated price per share for which underlying stock may be purchased (in the case of a call) or sold (in the case of a put) by theoption holder upon exercise of the option contract.4

 

Open interest: The total number of derivatives contracts traded that have not yet been liquidated either by an offsetting derivative transaction or by delivery.

 

Overtrading: Excessive broker trading in a discretionary account. Underwriters persuade brokerage clients to purchase some part of a new issue in return for the purchase by the underwriter of other securities from the clients at a premium. This premium is offset by the underwriting spread.

 

Hedged portfolio: A portfolio consisting of a long position in the stock and a long position in the put option on the stock, so as to be riskless and produce a return that equals the risk-free interest rate.

Trending News Headlines

The e-commerce company is working on a plan to list on a stock exchange in its home market, China more than three years after it bypassed domestic investors to go public in New York.

Amazon.com Inc’s top television shows drew more than 5 million people worldwide to its Prime shopping club by early 2017, according to company documents, revealing for the first time how the retailer’s bet on original video is paying off.

Incyte Targeted Therapy and Immuno-Oncology Portfolio to be Featured in 15 Abstracts at the AACR Annual Meeting 2018

The succession plans at JPMorgan and Goldman say a lot about where the companies—and the Street—are headed.

U.S. regulators are preparing to sanction Wells Fargo for receiving commissions on auto insurance policies it helped force on more than half a million drivers, people with direct knowledge of the probes told Reuters.

SAN DIEGO and TORONTO, March 15, 2018 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced that preclinical data for CG’806, its pan-FLT3/pan-BTK inhibitor, and APTO-253, its c-Myc inhibitor, will be presented in three separate posters at the 2018 AACR Annual Meeting in Chicago, Il.